« Back to Record
Citation APA

Machiels, J. P., Bossi, P., Menis, J., Lia, M., Fortpied, C., Liu, Y., Lhommel, R., Lemort, M., Schmitz, S., Canevari, S., De Cecco, L., Guzzo, M., Bianchi, R., Quattrone, P., Crippa, F., Duprez, T., Lalami, Y., Quiriny, M., De Saint Aubain, N., Clement, P. M. J. P., Coropciuc, R., Hauben, E., & Licitra, L. (2018). Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN). Annals of oncology, 29(4), 985-991. doi:10.1093/annonc/mdy013


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/276770

Machiels, J. P., Bossi, P., Menis, J., Lia, M., Fortpied, C., Liu, Y., Lhommel, R., Lemort, M., Schmitz, S., Canevari, S., De Cecco, L., Guzzo, M., Bianchi, R., Quattrone, P., Crippa, F., Duprez, T., Lalami, Y., Quiriny, M., De Saint Aubain, N., Clement, P. M. J. P., Coropciuc, R., Hauben, E., & Licitra, L. (2018). Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN). Annals of oncology, 29(4), 985-991. doi:10.1093/annonc/mdy013